Ariella T. Kornfeld
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ariella T. Kornfeld has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Mollie K. Meffert
Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
2 shared publications - Celeste Morales
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
1 shared publication - Daniel S. Jin
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication - Emily A. Eiss
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication John Robinson
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publicationManasi Inamdar
Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
1 shared publication
Latest Publications
- Open Access
- 16 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (42) , eaeh6791
Peripheral nerve injury alters metabolic function and neuronal excitability through the Lin28/let-7 pathway
Sensory neurons require efficient metabolic processes to reliably transmit information including touch, temperature, and noxious stimuli from peripheral to central nervous systems. Peripheral nerve injury is known to disrupt metabolic function resulting in aberrant sensory nervous system excitation, but molecular pathways linking nerve injury to persistent alterations in metabolism and neuronal activity have been incompletely understood. We find that a conserved metabolic regulator, RNA binding protein Lin28, is elevated in the somas of dorsal root ganglion (DRG) nociceptive neurons following nerve injury but exhibits a higher and more enduring local induction in peripheral sensory axons of the injured nerve. Growth suppressor let-7 family microRNAs (miRNAs), whose biogenesis is inhibited by Lin28, are down-regulated following injury, consistent with the spatiotemporal course of Lin28 induction. Genome-wide sensory neuron-specific and nociceptor-enriched profiling of miRNA:target RNA interactions reveals abundant let-7 miRNA targeting of metabolic transcripts in healthy sensory axons, which is diminished by nerve injury. Consistently, injured sciatic nerves exhibit disrupted cellular respiration near the site of nerve injury, which is alleviated by local restoration of let-7 miRNAs. Selective Lin28 knockout in nociceptive sensory neurons also alleviates the metabolic disturbances of nerve injury as well as suppressing injury-induced elevation of activity in ipsilateral peripheral sensory neurons and central spinal cord dorsal horn neurons. These results implicate the Lin28/let-7 pathway as a critical driver of metabolic dysregulation and the pathophysiology of heightened sensory nervous system activity following nerve injury.
- 16 October 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (42) , eaeh6791
Open AccessPeripheral nerve injury alters metabolic function and neuronal excitability through the Lin28/let-7 pathway
Sensory neurons require efficient metabolic processes to reliably transmit information including touch, temperature, and noxious stimuli from peripheral to central nervous systems. Peripheral nerve injury is known to disrupt metabolic function resulting in aberrant sensory nervous system excitation, but molecular pathways linking nerve injury to persistent alterations in metabolism and neuronal activity have been incompletely understood. We find that a conserved metabolic regulator, RNA binding protein Lin28, is elevated in the somas of dorsal root ganglion (DRG) nociceptive neurons following nerve injury but exhibits a higher and more enduring local induction in peripheral sensory axons of the injured nerve. Growth suppressor let-7 family microRNAs (miRNAs), whose biogenesis is inhibited by Lin28, are down-regulated following injury, consistent with the spatiotemporal course of Lin28 induction. Genome-wide sensory neuron-specific and nociceptor-enriched profiling of miRNA:target RNA interactions reveals abundant let-7 miRNA targeting of metabolic transcripts in healthy sensory axons, which is diminished by nerve injury. Consistently, injured sciatic nerves exhibit disrupted cellular respiration near the site of nerve injury, which is alleviated by local restoration of let-7 miRNAs. Selective Lin28 knockout in nociceptive sensory neurons also alleviates the metabolic disturbances of nerve injury as well as suppressing injury-induced elevation of activity in ipsilateral peripheral sensory neurons and central spinal cord dorsal horn neurons. These results implicate the Lin28/let-7 pathway as a critical driver of metabolic dysregulation and the pathophysiology of heightened sensory nervous system activity following nerve injury.
- Open Access
A human model of the neurodevelopmental metabolic shift
Summary: The neurodevelopmental metabolic shift transitions the metabolic pathways used by neurons to generate energy in order to critically support survival, growth, and functional maturation. To better understand metabolic regulation during human neuronal development and to facilitate the study of early neurodevelopmental disorders impacting this time window, establishing a combination of effective human model systems will be required. We report that a streamlined strategy using the genetic induction of neuronal differentiation by NGN2 expression recapitulates hallmarks of metabolic reprogramming associated with neurodevelopment. The approach is refined to increase the uniformity of differentiation, allowing reproducible high-throughput assessments. We validate appropriate readouts of metabolic function, including gene expression, cellular respiration, and mitochondrial morphology, which can be combined to present a cohesive assessment of metabolic status and reliance on oxidative phosphorylation relative to glycolysis. Collectively, the strategy presented will enhance the ability of investigators to gather foundational and disease-related insights into regulatory mechanisms of the metabolic shift critical to successful neuronal differentiation. Highlights: Establishes a model of the neurodevelopmental metabolic shift using human i 3 Neurons Characterizes metabolic correlates across neuronal differentiation Demonstrates strategies to assess cellular metabolism and bioenergetics in hPSCs and neurons Provides a uniform system to probe metabolic deficiencies in neurological disorders Motivation: Several approaches to investigate human neurodevelopmental metabolic reprogramming have been previously reported. However, prior strategies have largely relied on extrinsic factors to provide neurodevelopmental cues, which can impact the uniformity of differentiation as well as being costly, time-consuming, and often technically challenging. As impairments impacting cellular respiration impede proper neuronal development and metabolic deficiencies have been linked to neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, there is a need for efficient and robust models to investigate these early developmental mechanisms. Here, we report a strategy, incorporating an established neuronal differentiation model using induction of stably integrated Neurogenin-2 (NGN2) for rapid generation of excitatory neurons (i 3 Neurons), which we demonstrate can synchronously recapitulate changes associated with the neurodevelopmental metabolic shift.
Open AccessA human model of the neurodevelopmental metabolic shift
Summary: The neurodevelopmental metabolic shift transitions the metabolic pathways used by neurons to generate energy in order to critically support survival, growth, and functional maturation. To better understand metabolic regulation during human neuronal development and to facilitate the study of early neurodevelopmental disorders impacting this time window, establishing a combination of effective human model systems will be required. We report that a streamlined strategy using the genetic induction of neuronal differentiation by NGN2 expression recapitulates hallmarks of metabolic reprogramming associated with neurodevelopment. The approach is refined to increase the uniformity of differentiation, allowing reproducible high-throughput assessments. We validate appropriate readouts of metabolic function, including gene expression, cellular respiration, and mitochondrial morphology, which can be combined to present a cohesive assessment of metabolic status and reliance on oxidative phosphorylation relative to glycolysis. Collectively, the strategy presented will enhance the ability of investigators to gather foundational and disease-related insights into regulatory mechanisms of the metabolic shift critical to successful neuronal differentiation. Highlights: Establishes a model of the neurodevelopmental metabolic shift using human i 3 Neurons Characterizes metabolic correlates across neuronal differentiation Demonstrates strategies to assess cellular metabolism and bioenergetics in hPSCs and neurons Provides a uniform system to probe metabolic deficiencies in neurological disorders Motivation: Several approaches to investigate human neurodevelopmental metabolic reprogramming have been previously reported. However, prior strategies have largely relied on extrinsic factors to provide neurodevelopmental cues, which can impact the uniformity of differentiation as well as being costly, time-consuming, and often technically challenging. As impairments impacting cellular respiration impede proper neuronal development and metabolic deficiencies have been linked to neurodegenerative, neuropsychiatric, and neurodevelopmental disorders, there is a need for efficient and robust models to investigate these early developmental mechanisms. Here, we report a strategy, incorporating an established neuronal differentiation model using induction of stably integrated Neurogenin-2 (NGN2) for rapid generation of excitatory neurons (i 3 Neurons), which we demonstrate can synchronously recapitulate changes associated with the neurodevelopmental metabolic shift.